Home » Chiesi Group Acquires Zymenex, Enters Rare-Disease Market
Chiesi Group Acquires Zymenex, Enters Rare-Disease Market
August 27, 2013
Chiesi is purchasing Zymenex and related companies in an effort to enter the rare disease market.
Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Upcoming Events
-
21Oct